GALT - Galectin Therapeutics Inc Stock Price, Fair Value and News

$5.66+0.20 (+3.66%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

GALT Price Action

Last 7 days

-1.7%

Last 30 days

-5.7%

Last 90 days

21.2%

Trailing 12 Months

117.7%

GALT RSI Chart

GALT Valuation

Market Cap

364.9M

Price/Earnings (Trailing)

-9.78

Price/Free Cashflow

-11.92

GALT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

GALT Fundamentals

GALT Earnings

Earnings (TTM)

-37.3M

Earnings Growth (Yr)

27.06%

Earnings Growth (Qtr)

-8.82%

GALT Profitability

Return on Equity

29.77%

Return on Assets

-289.96%

Free Cashflow Yield

-8.39%

GALT Investor Care

Shares Dilution (1Y)

2.73%

Diluted EPS (TTM)

-0.59

GALT Alerts

3 major insider sales recently.

Revenue & Growth

About Galectin Therapeutics Inc

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

CEO	Mr. Joel Lewis
WEBSITE	https://galectintherapeutics.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	12

Galectin Therapeutics Inc Frequently Asked Questions

What is the ticker symbol for Galectin Therapeutics Inc? What does GALT stand for in stocks?

GALT is the stock ticker symbol of Galectin Therapeutics Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Galectin Therapeutics Inc (GALT)?

As of Wed Dec 03 2025, market cap of Galectin Therapeutics Inc is 364.92 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of GALT stock?

You can check GALT's fair value in chart for subscribers.

Is Galectin Therapeutics Inc a good stock to buy?

The fair value guage provides a quick view whether GALT is over valued or under valued. Whether Galectin Therapeutics Inc is cheap or expensive depends on the assumptions which impact Galectin Therapeutics Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GALT.

What is 5 year return on Galectin Therapeutics Inc's stock?

In the past 10 years, Galectin Therapeutics Inc has provided 0.114 (multiply by 100 for percentage) rate of return.